Shire Explores Robotic Pill Potential For Hemophilia

The company has linked up with Rani Therapeutics to develop a simple-to-swallow capsule that is able to provide an alternative to current injectable therapies for hemophilia A.

SC1712_Chalk Arrow_265447892_1200.jpg
New direction: Shire and Rani will explore oral therapies for hemophilia A • Source: Shutterstock

More from Deals

More from Business